NHS Blood and Transplant possesses the knowledge and background to support and project from small scale novel to large scale private manufacturing projects.
We are uniquely positioned to support both cell and gene therapy projects, with:
- over 20 years’ of experience with key subject matter experts within the cell and gene therapy field, supported by an established NHS infrastructure
- an extensive track record supporting numerous clinical trials worldwide, treating patients with range of infectious, malignant or inherited disorders.
Regionally, we have:
- a dedicated HTA / MHRA accredited Advanced Therapy laboratory to support the development of therapies from research, trial and commercialisation
- a Dedicated HTA / MHRA accredited Clinical Biotechnology centre producing GMP / HQ Viral Vectors and Plasmids
- 14x cleanrooms for spatially and campaign segregated manufacture of cell and gene therapies.
Watch to find out more about our gene therapies manufacturing facility
